Yuval Cohen resumes & CV records
Resumes
Yuval Cohen
Yuval Cohen
Location:
United States
Yuval Cohen, Age 44310 Beverley Rd, Brooklyn, NY 11218
Yuval Cohen Phones & Addresses
310 Beverley Rd, Brooklyn, NY 11218 (718) 854-7688
310 Beverley Rd #5B, Brooklyn, NY 11218 (718) 854-6795
4925 Desert Cove Ave, Scottsdale, AZ 85254 (480) 209-1563
Maricopa, AZ
Delray Beach, FL
Mentions for Yuval Cohen
Publications & IP owners
Us Patents
Use Of Lipid Conjugates In The Treatment Of Diseases Or Disorders Of The Eye
US Patent:
2008011, May 15, 2008
Filed:
Nov 14, 2007
Appl. No.:
11/984223
Inventors:
Saul Yedgar - Jerusalem, IL
Yuval Cohen - New York NY, US
Yuval Cohen - New York NY, US
International Classification:
A61K 31/727
A61K 31/685
A61K 31/715
A61K 31/717
A61P 27/02
A61K 31/718
A61K 31/726
A61K 31/685
A61K 31/715
A61K 31/717
A61P 27/02
A61K 31/718
A61K 31/726
US Classification:
514 56, 514 23, 514 57, 514 60, 514 62, 514 78
Abstract:
In one embodiment, the invention provides a method of treating, reducing the incidence, reducing the severity or pathogenesis of an eye disease or disorder in a subject, including, inter alia, retinal detachment, macular degeneration, glaucoma or retinopathy, comprising the step of administering an effective amount of a lipid or phospholipid moiety bound optionally via a spacer to a physiologically acceptable monomer, dimer, oligomer, or polymer via an ester or amide bond, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof. This invention also provides a contact lens solution comprising a lipid or phospholipid moiety bound optionally via a spacer to a physiologically acceptable monomer, dimer, oligomer, or polymer via an ester or amide bond, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof.
Lipid-Polymer Conjugates, Their Preparation And Uses Thereof
US Patent:
2011013, Jun 2, 2011
Filed:
May 11, 2010
Appl. No.:
12/997014
Inventors:
Saul Yedgar - Jerusalem, IL
Yuval Cohen - New York NY, US
Joseph V. Bondi - Collegeville PA, US
Yuval Cohen - New York NY, US
Joseph V. Bondi - Collegeville PA, US
International Classification:
C08B 37/10
C08B 37/08
C08B 37/00
C08B 37/08
C08B 37/00
US Classification:
536 21, 536 2913, 536 291
Abstract:
This invention provides low molecular weight lipid-GAG and phospholipids-GAG conjugates and methods of use thereof in suppressing, inhibiting, preventing, or treating a pathogenic effect on a cell, including, inter alia, infection with intracellular pathogens.
Contact Lens Compositions
US Patent:
2008011, May 15, 2008
Filed:
Nov 14, 2007
Appl. No.:
11/984224
Inventors:
Saul Yedgar - Jerusalem, IL
Yuval Cohen - New York NY, US
Yuval Cohen - New York NY, US
International Classification:
A61K 9/00
A61P 27/00
A61P 27/00
US Classification:
424429
Abstract:
In one embodiment, the invention provides a contact lens comprising a lipid or phospholipid moiety bound optionally via a spacer to a physiologically acceptable monomer, dimer, oligomer, or polymer via an ester or amide bond, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof.
Use Of Lipid Conjugates In Cystic Fibrosis And Applications Thereof
US Patent:
2014010, Apr 10, 2014
Filed:
Nov 4, 2013
Appl. No.:
14/071578
Inventors:
- New York NY, US
- Jerusalem, IL
Yuval Cohen - Brooklyn NY, US
- Jerusalem, IL
Yuval Cohen - Brooklyn NY, US
Assignee:
Columbia University - New York NY
Yissum Research Development Company of The Hebrew University of Jerusalem LTD - Jerusalem
Yissum Research Development Company of The Hebrew University of Jerusalem LTD - Jerusalem
International Classification:
A61K 47/48
US Classification:
514 59, 514 54
Abstract:
This invention provides for the use of compounds represented by the structure of the general formula (A):wherein L is a lipid or a phospholipid, Z is either nothing, ethanolamine, serine, inositol, choline, or glycerol, Y is either nothing or a spacer group ranging in length from 2 to 30 atoms, X is a physiologically acceptable monomer, dimer, oligomer, or polymer, wherein X is a glycosaminoglycan; and n is a number from 1 to 1000, wherein any bond between L, Z, Y and X is either an amide or an esteric bond in treating a subject suffering from cystic fibrosis, reducing or delaying the mortality of a subject suffering from cystic fibrosis or ameliorating symptoms associated with cystic fibrosis.
Amazon
Introduction To Industrial Engineering, Second Edition (Industrial Innovation Series) By Avraham Shtub (2015-12-22)
Author:
Avraham Shtub;Yuval Cohen
Publisher:
CRC Press
Binding:
Hardcover
Medical Billing Networks And Processes : Profitable And Compliant Revenue Cycle Management In The Internet Age (Hardcover)--By Yuval Lirov [2009 Edition]
Author:
Phd Yuval Lirov, Alison Cohen Yuval Lirov
Publisher:
Yuval Lirov
Binding:
Hardcover
Introduction To Industrial Engineering, Second Edition (Industrial Innovation Series)
Author:
Avraham Shtub, Yuval Cohen
Publisher:
CRC Press
Binding:
Hardcover
Pages:
436
ISBN #:
1498706010
EAN Code:
9781498706018
A Firsthand Look at the Role of the Industrial Engineer The industrial engineer helps decide how best to utilize an organization’s resources to achieve company goals and objectives. Introduction to Industrial Engineering, Second Edition offers an in-depth analysis of the industrial engineering prof...
Discrete Arma Model For Natural Resonances In Electromagnetic And Acoustic Scattering
Author:
Yuval Cohen
Publisher:
PN
Binding:
Paperback
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.